We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
401
DELISTED
Infinera Corporation Common Stock
INFN
| $12.2M | 0.05% |
+1,191,300
| New | +$11.6M |
|
402
GE Aerospace
GE
$373B
| $12.1M | 0.05% |
+180,228
| New | +$12M |
|
403
Louisiana-Pacific
LPX
$5.01B
| $12.1M | 0.05% |
200,400
+167,800
| +515% | +$10.7M |
|
404
Globus Medical
GMED
$10.7B
| $12.1M | 0.05% |
155,800
+124,500
| +398% | +$8.85M |
|
405
eHealth
EHTH
$42.2M
| $12M | 0.05% |
206,200
+74,500
| +57% | +$4.9M |
|
406
Cogent Biosciences
COGT
$6.81B
| $12M | 0.05% |
1,483,095
+871,595
| +143% | +$7.36M |
|
407
First Bancorp
FBP
$4.43B
| $12M | 0.05% |
1,006,100
-1,067,600
| -51% | -$13.2M |
|
|
MGI
408
DELISTED
MoneyGram International, Inc. New
MGI
| $11.9M | 0.05% |
1,182,471
+136,939
| +13% | +$1.16M |
|
|
ADMS
409
DELISTED
Adamas Pharmaceuticals
ADMS
| $11.9M | 0.05% |
+2,251,255
| New | +$11.7M |
|
410
Scorpio Tankers
STNG
$3.87B
| $11.8M | 0.05% |
536,600
+324,400
| +153% | +$6.59M |
|
411
AvalonBay Communities
AVB
$26.6B
| $11.7M | 0.05% |
+56,197
| New | +$11.2M |
|
|
TRTN
412
DELISTED
Triton International Limited
TRTN
| $11.7M | 0.05% |
223,600
+196,000
| +710% | +$10.4M |
|
|
QVCGA
413
DELISTED
QVC Group Inc Series A
QVCGA
| $11.7M | 0.05% |
17,876
+4,370
| +32% | +$2.8M |
|
414
Myriad Genetics
MYGN
$285M
| $11.7M | 0.05% |
381,805
-16,043
| -4% | -$464K |
|
415
Five Below
FIVE
$11.9B
| $11.7M | 0.05% |
60,367
-120,937
| -67% | -$23.1M |
|
416
Chefs' Warehouse
CHEF
$4.55B
| $11.6M | 0.05% |
+365,900
| New | +$11.7M |
|
417
Guardant Health
GH
$21.4B
| $11.6M | 0.05% |
+93,596
| New | +$12.6M |
|
418
Sociedad Química y Minera de Chile
SQM
$19.2B
| $11.5M | 0.05% |
+243,200
| New | +$12M |
|
419
Atara Biotherapeutics
ATRA
$72.5M
| $11.5M | 0.05% |
29,596
+8,112
| +38% | +$2.89M |
|
420
Old Dominion Freight Line
ODFL
$44.3B
| $11.4M | 0.05% |
89,928
-81,034
| -47% | -$10.4M |
|
|
AGEN
421
Agenus
AGEN
$321M
| $11.2M | 0.05% |
104,234
-29,958
| -22% | -$2.25M |
|
422
Ascendis Pharma A/S
ASND
$16.1B
| $11.2M | 0.05% |
85,100
+50,100
| +143% | +$6.68M |
|
423
CALL
Sunrun
RUN
$2.33B
| $11.2M | 0.05% |
200,000
+100,000
| +100% | +$4.83M |
|
424
MacroGenics
MGNX
$236M
| $11.1M | 0.05% |
413,100
-164,600
| -28% | -$4.82M |
|
425
SkinHealth Systems
SKIN
$87.4M
| $11M | 0.05% |
657,200
-192,800
| -23% | -$2.64M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.